Ruth E. Bailey
Impact in
- Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- Clostridium difficile and Clostridium perfringens research 1
-
- Analytical Chemistry and Chromatography 2
- Co-authors
- Thomas H. Eichhold (3 shared papers)Steven H. Hoke (3 shared papers)J. David Pinkston (1 shared paper)Stephen W. Morrall (1 shared paper)Lesley A. Stanley (1 shared paper)Julie A. Skare (1 shared paper)Marilyn J. Aardema (1 shared paper)Ting Hu (1 shared paper)
- Journals
- New England Journal of Medicine (4 papers)Journal of Mass Spectrometry (1 paper)Clinical Infectious Diseases (1 paper)Vaccine (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ruth E. Bailey
12 papers receiving 15.6k citations
Ruth E. Bailey's Hit Papers
Peers
Comparison fields: 5 of 154
- Infectious Diseases 10.3k
- Modeling and Simulation 575
- Health 967
- Toxicology 238
- Immunology 720
Countries citing papers authored by Ruth E. Bailey
This map shows the geographic impact of Ruth E. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Bailey more than expected).
Fields of papers citing papers by Ruth E. Bailey
This network shows the impact of papers produced by Ruth E. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Bailey. The network helps show where Ruth E. Bailey may publish in the future.
Co-authors
The 21 scholars most cited alongside Ruth E. Bailey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Hit paper breakdown → | 2020 | 11540 |
| 2 | Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates Hit paper breakdown → | 2020 | 2111 |
| 3 | Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Hit paper breakdown → | 2020 | 1270 |
| 4 | Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents Hit paper breakdown → | 2021 | 688 |
| 5 | SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 Hit paper breakdown → | 2021 | 289 |
| 6 | 2000 | 60 | |
| 7 | 2009 | 49 | |
| 8 | 2021 | 46 | |
| 9 | 2000 | 37 | |
| 10 | 2000 | 36 | |
| 11 | 2024 | 17 | |
| 12 | 2023 | 1 |
About Ruth E. Bailey
Ruth E. Bailey is a scholar working on Infectious Diseases, Spectroscopy, Toxicology, Analytical Chemistry and Cancer Research, having authored 12 papers that have together received 16.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Analytical Chemistry and Chromatography (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Carcinogens and Genotoxicity Assessment (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Forensic Toxicology and Drug Analysis (1 paper) and Analytical chemistry methods development (1 paper). The work is most often cited by research in Infectious Diseases (10.3k citations), Modeling and Simulation (575 citations), Health (967 citations), Toxicology (238 citations) and Immunology (720 citations). Ruth E. Bailey has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Thomas H. Eichhold, Steven H. Hoke, J. David Pinkston, Stephen W. Morrall, Lesley A. Stanley, Julie A. Skare, Marilyn J. Aardema, Ting Hu, Kenneth J. Koury and Xia Xu. Their work appears in journals such as New England Journal of Medicine, Journal of Mass Spectrometry, Clinical Infectious Diseases, Vaccine and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.